Eprosartan mesylate

Known as: (E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic Acid, Monomethanesulfonate, 2-Thiophenepropanoic Acid, alpha-((2-butyl-1-((4-carboxyphenyl)methyl)-1H-imidazol-5-yl)methylene)-,(E)-, Monomethanesulfonate 
The mesylate salt form of eprosartan, a non-biphenyl, non-tetrazole, nonpeptide angiotensin II antagonist with antihypertensive activity. Eprosartan… (More)

Topic mentions per year

Topic mentions per year

1999-2017
02419992017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The objective of the present work was to formulate, optimize and evaluate the potential of novel soft nanovesicles i.e. nano… (More)
Is this relevant?
2016
2016
The present investigation is aimed to design a statistically optimized self-microemulsifying drug delivery system (SMEDDS) of… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2015
2015
Objective: A simple, specific, accurate and precise Rp-high-performance liquid chromatography method was developed and validated… (More)
  • figure 4
  • figure 5
  • figure 8
  • table 1
  • table 2
Is this relevant?
2011
2011
The title compound, eprosartan mesylate {systematic name: 2-butyl-1-(4-carb-oxy-benz-yl)-5-[(E)-2-carb-oxy-3-(thio-phen-2-yl)prop… (More)
  • table 1
  • figure 1
Is this relevant?
2004
2004
BACKGROUND Isolated systolic hypertension (ISH) is a common and particularly poorly controlled form of hypertension. OBJECTIVE… (More)
Is this relevant?
2004
2004
BACKGROUND Evidence suggests that antihypertensive agents may have differential effects on systolic blood pressure (SBP) and that… (More)
Is this relevant?
2004
2004
This was a double-blind, randomized, placebo-controlled multicenter, titration-to-effect study of eprosartan in patients ⩾60… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
2003
2003
We have optimized a micellar electrokinetic capillary chromatographic method for the separation of six angiotensin-II-receptor… (More)
Is this relevant?
2002
2002
In 20 patients with ischemic stroke and moderate or severe arterial hypertension the effectiveness of eprosartan mesilat (Teveten… (More)
Is this relevant?
1999
1999
Eprosartan mesylate (SKF 108566-J; EM) is an antihypertensive agent approved for marketing in the USA. EM dihydrate was prepared… (More)
Is this relevant?